| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MOL.0B013E328051B4FE |
| P698 | PubMed publication ID | 17353662 |
| P2093 | author name string | Nancy R Webb | |
| Deneys R van der Westhuyzen | |||
| Frederick C de Beer | |||
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 147-151 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Current Opinion in Lipidology | Q15758705 |
| P1476 | title | HDL cholesterol transport during inflammation | |
| P478 | volume | 18 |
| Q37510074 | 9β Polymorphism of the glucocorticoid receptor gene appears to have limited impact in patients with Addison's disease |
| Q58710934 | AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation |
| Q34112680 | ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport |
| Q45023613 | Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study |
| Q38543425 | Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights |
| Q28116206 | Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis |
| Q35960732 | Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients |
| Q54950854 | Aortic Aneurysms. |
| Q36982887 | Association of blood lipids, creatinine, albumin, and CRP with socioeconomic status in Malawi |
| Q28534795 | Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients |
| Q34546651 | Autoimmune‐mediated reduction of high‐density lipoprotein–cholesterol and paraoxonase 1 activity in systemic lupus erythematosus–prone gld mice |
| Q34635305 | Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels |
| Q51548302 | Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice. |
| Q33993673 | Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A |
| Q33604003 | Dysfunctional HDL as a diagnostic and therapeutic target |
| Q39441003 | Effect of reconstituted discoidal high-density lipoproteins on lipid mobilization in RAW 264.7 and CHOK1 cells |
| Q41759940 | Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. |
| Q33911023 | Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue |
| Q37190568 | Evaluating health and disease in Sub-Saharan Africa: minimally invasive collection of plasma in the Malawi Longitudinal Study of Families and Health (MLSFH) |
| Q28535779 | HDL-apoA-I exchange: rapid detection and association with atherosclerosis |
| Q51730717 | High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase. |
| Q35547011 | High density lipoprotein structure-function and role in reverse cholesterol transport |
| Q38059859 | High-density lipoprotein function, dysfunction, and reverse cholesterol transport |
| Q38304297 | Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases |
| Q35166941 | Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway |
| Q34187954 | Impact of serum amyloid A on high density lipoprotein composition and levels |
| Q44430195 | Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. |
| Q37077796 | Inflammation impairs reverse cholesterol transport in vivo. |
| Q35992445 | Inflammation modulates human HDL composition and function in vivo. |
| Q39025753 | Inflammation, remodeling, and other factors affecting HDL cholesterol efflux |
| Q88984493 | Inflammation, von Willebrand factor, and ADAMTS13 |
| Q35886286 | Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity |
| Q33743503 | Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis |
| Q38543421 | Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A. |
| Q36927446 | Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysis. |
| Q57113485 | Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis |
| Q33570203 | Loss of sex difference in high-density lipoprotein cholesterol in diabetic women during acute stress |
| Q33741235 | Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) |
| Q34291776 | Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein |
| Q27309035 | No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic mice |
| Q37257476 | Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib |
| Q34140067 | Prion-like aggregates: infectious agents in human disease |
| Q37222723 | Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population |
| Q33581415 | Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism |
| Q48028286 | Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis |
| Q36430779 | Serum amyloid A impairs the antiinflammatory properties of HDL |
| Q47205995 | Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response |
| Q53157198 | Serum amyloid A1 levels and amyloid deposition following a high-fat diet challenge in transgenic mice overexpressing hepatic serum amyloid A1. |
| Q28291806 | Serum amyloid A: an acute-phase protein involved in tumour pathogenesis |
| Q37041836 | Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia |
| Q35099718 | Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever. |
| Q36610558 | The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. |
| Q46961293 | The withdrawal of torcetrapib from drug development: implications for the future of drugs that alter HDL metabolism |
| Q30380038 | Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids |
| Q35886290 | Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL. |
| Q61809485 | Von Willebrand Factor Adhesive Activity and ADAMTS13 Protease Activity in HIV-1-Infected Men |
| Q34776276 | Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport |
Search more.